Molla A - Search Results

1

Peptides with dual binding specificity for HLA-A2 and HLA-E are encoded by alternatively spliced isoforms of the antioxidant enzyme peroxiredoxin 5.

Sensi M, Pietra G, Molla A, Nicolini G, Vegetti C, Bersani I, Millo E, Weiss E, Moretta L, Mingari MC, Anichini A. Sensi M, et al. Among authors: molla a. Int Immunol. 2009 Mar;21(3):257-68. doi: 10.1093/intimm/dxn141. Epub 2009 Jan 30. Int Immunol. 2009. PMID: 19181932

2

Autologous dendritic cells derived from CD34+ progenitors and from monocytes are not functionally equivalent antigen-presenting cells in the induction of melan-A/Mart-1(27-35)-specific CTLs from peripheral blood lymphocytes of melanoma patients with low frequency of CTL precursors.

Mortarini R, Anichini A, Di Nicola M, Siena S, Bregni M, Belli F, Molla A, Gianni AM, Parmiani G. Mortarini R, et al. Among authors: molla a. Cancer Res. 1997 Dec 15;57(24):5534-41. Cancer Res. 1997. PMID: 9407964

3

An expanded peripheral T cell population to a cytotoxic T lymphocyte (CTL)-defined, melanocyte-specific antigen in metastatic melanoma patients impacts on generation of peptide-specific CTLs but does not overcome tumor escape from immune surveillance in metastatic lesions.

Anichini A, Molla A, Mortarini R, Tragni G, Bersani I, Di Nicola M, Gianni AM, Pilotti S, Dunbar R, Cerundolo V, Parmiani G. Anichini A, et al. Among authors: molla a. J Exp Med. 1999 Sep 6;190(5):651-67. doi: 10.1084/jem.190.5.651. J Exp Med. 1999. PMID: 10477550 Free PMC article.

4

Lack of terminally differentiated tumor-specific CD8+ T cells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanoma.

Mortarini R, Piris A, Maurichi A, Molla A, Bersani I, Bono A, Bartoli C, Santinami M, Lombardo C, Ravagnani F, Cascinelli N, Parmiani G, Anichini A. Mortarini R, et al. Among authors: molla a. Cancer Res. 2003 May 15;63(10):2535-45. Cancer Res. 2003. PMID: 12750277

5

Differentiation of CD8+ T cells from tumor-invaded and tumor-free lymph nodes of melanoma patients: role of common gamma-chain cytokines.

Anichini A, Scarito A, Molla A, Parmiani G, Mortarini R. Anichini A, et al. Among authors: molla a. J Immunol. 2003 Aug 15;171(4):2134-41. doi: 10.4049/jimmunol.171.4.2134. J Immunol. 2003. PMID: 12902520

6

Apoptosis protease activator protein-1 expression is dispensable for response of human melanoma cells to distinct proapoptotic agents.

Zanon M, Piris A, Bersani I, Vegetti C, Molla A, Scarito A, Anichini A. Zanon M, et al. Among authors: molla a. Cancer Res. 2004 Oct 15;64(20):7386-94. doi: 10.1158/0008-5472.CAN-04-1640. Cancer Res. 2004. PMID: 15492260

7

Immunogenicity without immunoselection: a mutant but functional antioxidant enzyme retained in a human metastatic melanoma and targeted by CD8(+) T cells with a memory phenotype.

Sensi M, Nicolini G, Zanon M, Colombo C, Molla A, Bersani I, Lupetti R, Parmiani G, Anichini A. Sensi M, et al. Among authors: molla a. Cancer Res. 2005 Jan 15;65(2):632-40. Cancer Res. 2005. PMID: 15695408

8

Mutually exclusive NRASQ61R and BRAFV600E mutations at the single-cell level in the same human melanoma.

Sensi M, Nicolini G, Petti C, Bersani I, Lozupone F, Molla A, Vegetti C, Nonaka D, Mortarini R, Parmiani G, Fais S, Anichini A. Sensi M, et al. Among authors: molla a. Oncogene. 2006 Jun 8;25(24):3357-64. doi: 10.1038/sj.onc.1209379. Epub 2006 Feb 6. Oncogene. 2006. PMID: 16462768

9

Association of antigen-processing machinery and HLA antigen phenotype of melanoma cells with survival in American Joint Committee on Cancer stage III and IV melanoma patients.

Anichini A, Mortarini R, Nonaka D, Molla A, Vegetti C, Montaldi E, Wang X, Ferrone S. Anichini A, et al. Among authors: molla a. Cancer Res. 2006 Jun 15;66(12):6405-11. doi: 10.1158/0008-5472.CAN-06-0854. Cancer Res. 2006. PMID: 16778219

10

Coexpression of NRASQ61R and BRAFV600E in human melanoma cells activates senescence and increases susceptibility to cell-mediated cytotoxicity.

Petti C, Molla A, Vegetti C, Ferrone S, Anichini A, Sensi M. Petti C, et al. Among authors: molla a. Cancer Res. 2006 Jul 1;66(13):6503-11. doi: 10.1158/0008-5472.CAN-05-4671. Cancer Res. 2006. PMID: 16818621

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

466 results

Search Page

Filters